Shō Nogami

Recent publications · Crossref

5 total works indexed

1. Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer

   · 2018 · cited 4,578x

2. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

   · 2018 · cited 3,173x

3. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

   · 2019 · cited 1,863x

4. Sudden Cardiac Arrest Associated with Early Repolarization

   · 2008 · cited 1,229x

5. Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial

   · 2019 · cited 811x

via Crossref · CC0